HomeComparePGNN vs PFE

PGNN vs PFE: Dividend Comparison 2026

PGNN yields 16.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PGNN wins by $7.4K in total portfolio value
10 years
PGNN
PGNN
● Live price
16.00%
Share price
$12.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.0K
Annual income
$4,284.03
Full PGNN calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PGNN vs PFE

📍 PGNN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPGNNPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PGNN + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PGNN pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PGNN
Annual income on $10K today (after 15% tax)
$1,360.00/yr
After 10yr DRIP, annual income (after tax)
$3,641.43/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $18,678.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PGNN + PFE for your $10,000?

PGNN: 50%PFE: 50%
100% PFE50/50100% PGNN
Portfolio after 10yr
$53.3K
Annual income
$15,271.37/yr
Blended yield
28.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PGNN
No analyst data
Altman Z
-0.9
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PGNN buys
0
PFE buys
0
No recent congressional trades found for PGNN or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPGNNPFE
Forward yield16.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$57.0K$49.6K
Annual income after 10y$4,284.03$26,258.71
Total dividends collected$28.6K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PGNN vs PFE ($10,000, DRIP)

YearPGNN PortfolioPGNN Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,300$1,600.00$9,153$693.39+$3.1KPGNN
2$15,000$1,839.25$8,593$849.25+$6.4KPGNN
3$18,147$2,096.29$8,336$1,066.78+$9.8KPGNN
4$21,787$2,370.08$8,437$1,384.80+$13.3KPGNN
5$25,971$2,659.38$9,013$1,875.40+$17.0KPGNN
6$30,752$2,962.76$10,306$2,680.72+$20.4KPGNN
7$36,183$3,278.63$12,820$4,101.38+$23.4KPGNN
8$42,322$3,605.31$17,673$6,826.70+$24.6KPGNN
9$49,225$3,941.04$27,543$12,591.86+$21.7KPGNN
10$56,955$4,284.03$49,560$26,258.71+$7.4KPGNN

PGNN vs PFE: Complete Analysis 2026

PGNNStock

Paragon Financial Solutions, Inc., through its subsidiary, Paragon Bank, provides various banking products and services to individuals, and small and mid-sized businesses in the United States. It offers deposit products, including checking accounts, savings accounts, money market savings accounts, certificates of deposit, and IRAs. The company also provides commercial loan products comprising working capital loans, accounts receivable/inventory lines of credit, equipment financing, commercial auto/truck financing, business acquisition financing, letters of credit, SBA/USDA lending, and owner-and non-owner-occupied commercial real estate loans; and mortgage loans, such as purchase, refinance, conventional mortgage, federal housing administration, veterans affairs, affordable home, home equity, and medical specialist loans. In addition, it offers private banking services, such as depository and personal financial services, as well as special purchases, residential mortgages, home equity, construction and renovation, and vacation and second homes loan and credit services; cash management solutions consisting of liquidity, fraud prevention, and payables and receivables management; and wealth solutions, including equities, mutual funds, bonds, and annuity products and services. Further, the company provides insurance solutions, such as property, general liability, group medical plans, long and short-term disability, professional liability, workers compensation, truckers/cargo, auto, home, umbrella, aviation, and surety bonds, as well as employee dental, vision, and life insurance. It also offers mobile, online, phone, and internet banking services. The company operates approximately 150 ATM locations in the Memphis metro area. Paragon Financial Solutions, Inc. was founded in 2004 and is based in Memphis, Tennessee.

Full PGNN Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PGNN vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PGNN vs SCHDPGNN vs JEPIPGNN vs OPGNN vs KOPGNN vs MAINPGNN vs JNJPGNN vs MRKPGNN vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.